Office reopening poses serious risks, with or without virus testing
Without a vaccine for the coronavirus, it is clear that reopening offices is a serious risk for capital markets businesses. What firms need are strict distancing measures, facial masks and hand sanitiser — but also, crucially, access to frequent testing for the virus and the antibody.But that is a path fraught with difficulty.
Without a vaccine, the world will not be rid of the coronavirus.
Many think a vaccine won’t be found till 2021. But before then, companies will be reopening offices as the daily death figures fall and lockdowns are eased.Corporate management must therefore wrestle with matching up the ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org